NKGen Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 14, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7	24	60	-	-
Market Cap Growth	-33.80%	-60.80%	-	-	-
Enterprise Value	60	52	71	-	-
Last Close Price	0.06	0.66	2.75	9.95	9.69
PB Ratio	-0.11	-0.34	-1.03	-	-
Debt / Equity Ratio	-0.76	-0.76	-0.34	7.70	-1.37
Asset Turnover	-	-	-	0.00	-
Quick Ratio	0.00	0.00	0.00	0.01	0.01
Current Ratio	0.04	0.04	0.05	0.02	0.01
Return on Assets (ROA)	-103.04%	-103.04%	-113.32%	-88.47%	-
Return on Invested Capital (ROIC)	-	-	-	-110.60%	-
Return on Capital Employed (ROCE)	64.60%	64.60%	129.50%	-1532.20%	58.00%
Earnings Yield	-593.44%	-187.66%	-137.81%	-	-
FCF Yield	-	-88.48%	-36.46%	-	-
Buyback Yield / Dilution	-86.88%	-86.88%	-142.70%	55.40%	-

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.